Ani Pharmaceuticals (ANIP) Prepaid Assets (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Prepaid Assets of $22.1 million for Q1 2026, down 35.45% sequentially from $34.2 million in Q4 2025, and down 5.31% YoY from $23.3 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Prepaid Assets (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $22.1 million in Q1 2026.
- Quarterly Prepaid Assets fell 5.31% year-over-year to $22.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.1 million (down 5.31% YoY) and the FY2025 annual result came in at $34.2 million, up 90.35% from the prior year.
- Prepaid Assets retreated to $22.1 million in Q1 2026 per ANIP's latest filing, from $34.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $34.2 million in Q4 2025 and troughed at $5.0 million in Q3 2022.
- A 5-year average of $14.7 million and a median of $15.1 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets decreased 11.03% in 2023, then jumped 133.49% in 2024.
- Over 5 years, Prepaid Assets stood at $8.4 million in 2022, then soared by 107.46% to $17.4 million in 2023, then climbed by 3.3% to $18.0 million in 2024, then surged by 90.35% to $34.2 million in 2025, then slumped by 35.45% to $22.1 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $22.1 million, $34.2 million, and $18.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.94 Mn |
| Mar 31, 2026 | 22.09 Mn |
| Dec 31, 2025 | 34.22 Mn |
| Sep 30, 2025 | 18.55 Mn |
| Jun 30, 2025 | 15.11 Mn |
| Mar 31, 2025 | 23.33 Mn |
| Dec 31, 2024 | 17.98 Mn |
| Sep 30, 2024 | 17.48 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 17.40 Mn |
| Sep 30, 2023 | 10.69 Mn |
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 8.39 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 6.03 Mn |
| Mar 31, 2022 | 7.73 Mn |
| Dec 31, 2021 | 7.59 Mn |
| Sep 30, 2021 | 4.70 Mn |